{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:05:32Z","timestamp":1783605932384,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Science and Engineering: C"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.msec.2019.110620","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T08:41:41Z","timestamp":1578386501000},"page":"110620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Surface engineered nanoliposomal platform for selective lymphatic uptake of asenapine maleate: In vitro and in vivo studies"],"prefix":"10.1016","volume":"109","author":[{"given":"Renuka S.","family":"Managuli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Tzu-Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid Muhammad","family":"Faruqu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhjieet","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanyog","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khuloud T.","family":"Al-Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Mutalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.msec.2019.110620_bb0005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/17425247.2018.1503249","article-title":"Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs","volume":"15","author":"Managuli","year":"2018","journal-title":"Expert. Opin. Drug. Deliv."},{"issue":"7","key":"10.1016\/j.msec.2019.110620_bb0010","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/nnm-2018-0289","article-title":"Asenapine maleate-loaded nanostructured lipid carriers: optimization and in vitro, ex vivo and in vivo evaluations","volume":"14","author":"Managuli","year":"2019","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.msec.2019.110620_bb0015","first-page":"190","article-title":"Formulation development and evaluation of sublingual film of asenapine maleate","volume":"4","author":"Kapadia","year":"2013","journal-title":"Pharma Science Monitor"},{"issue":"2","key":"10.1016\/j.msec.2019.110620_bb0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/03639045.2016.1236808","article-title":"Pharmacodynamic and pharmacokinetic investigation of cyclodextrin-mediated asenapine maleate in situ nasal gel for improved bioavailability","volume":"43","author":"Kulkarni","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.msec.2019.110620_bb0025","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1039\/C5RA19793G","article-title":"Intranasal delivery of asenapine loaded nanostructured lipid carriers: formulation, characterization, pharmacokinetic and behavioural assessment","volume":"6","author":"Singh","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.msec.2019.110620_bb0030","first-page":"1","article-title":"Peyer\u2019s patches: the immune sensors of the intestine","volume":"2010","author":"Jung","year":"2010","journal-title":"Int. J. Inflam."},{"key":"10.1016\/j.msec.2019.110620_bb0035","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mi.2013.30","article-title":"Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium","volume":"6","author":"Mabbott","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.msec.2019.110620_bb0040","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1128\/IAI.66.3.1237-1243.1998","article-title":"M-cell surface \u03b21 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer\u2019s patch M cells","volume":"66","author":"Clark","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.msec.2019.110620_bb0045","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3748\/wjg.v13.i10.1477","article-title":"Intestinal M cells: the fallible sentinels?","volume":"13","author":"Miller","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.msec.2019.110620_bb0050","doi-asserted-by":"crossref","unstructured":"Fievez V, Plapied L, des Rieux A, Pourcelle V, Freichels H, Wascotte V, Vanderhaeghen ML, Jer\u00f4me C, Vanderplasschen A, Marchand-Brynaert J, Schneider YJ, Pr\u00e9at V. Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination. Eur. J. Pharm. Biopharm.. 2009, 73(1):16\u201324.","DOI":"10.1016\/j.ejpb.2009.04.009"},{"key":"10.1016\/j.msec.2019.110620_bb0055","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.addr.2012.10.007","article-title":"Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery","volume":"65","author":"Yun","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.msec.2019.110620_bb0060","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ijpharm.2013.03.034","article-title":"Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization","volume":"454","author":"Shete","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2019.110620_bb0065","first-page":"425","article-title":"In-vitro cellular uptake and transport study of 9-nitrocamptothecin PLGA nanoparticles across Caco-2 cell monolayer model","volume":"10","author":"Derakhshandeh","year":"2011","journal-title":"Iran. J. Pharm. Res."},{"issue":"2","key":"10.1016\/j.msec.2019.110620_bb0070","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1124\/jpet.106.107847","article-title":"Identification of cell adhesion molecules in the human follicle-associated epithelium that improve nanoparticle uptake into the Peyer\u2019s patches","volume":"319","author":"Gullberg","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.msec.2019.110620_bb0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.addr.2016.07.007","article-title":"Oral absorption of peptides and nanoparticles across the human intestine: opportunities, limitations and studies in human tissues","volume":"106","author":"Lundquist","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.msec.2019.110620_bb0080","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41598-017-18573-7","article-title":"Use of nanoparticle concentration as a tool to understand the structural properties of colloids","volume":"8","author":"Ribeiro","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msec.2019.110620_bb0085","doi-asserted-by":"crossref","first-page":"21585","DOI":"10.1021\/acsami.6b06903","article-title":"Techniques for accurate sizing of gold nanoparticles using Dynamic Light Scattering with particular application to chemical and biological sensing based on aggregate formation","volume":"8","author":"Zheng","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.msec.2019.110620_bb0090","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.bbamem.2012.06.019","article-title":"Comparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methods","volume":"1818","author":"Nakamura","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.msec.2019.110620_bb0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0005-2736(90)90267-R","article-title":"Proteinliposome conjugates with defined size distributions","volume":"1028","author":"Loughrey","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.msec.2019.110620_bb0100","doi-asserted-by":"crossref","first-page":"96437","DOI":"10.1039\/C5RA14588K","article-title":"Improved oral bioavailability of docetaxel by nanostructured lipid carriers: in vitro characteristics, in vivo evaluation and intestinal transport studies","volume":"5","author":"Fang","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.msec.2019.110620_bb0105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/2230-973X.167661","article-title":"Nanostructured lipid carriers: an emerging platform for improving oral bioavailability of lipophilic drugs","volume":"5","author":"Khan","year":"2015","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.msec.2019.110620_bb0110","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.bbamem.2011.05.019","article-title":"Plant actin controls membrane permeability","volume":"1808","author":"Hohenberger","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.msec.2019.110620_bb0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/2230-973X.187351","article-title":"Preparation and evaluation of a novel oral delivery system for low molecular weight heparin","volume":"6","author":"Lavanya","year":"2016","journal-title":"Int. J. Pharma. Investig."},{"key":"10.1016\/j.msec.2019.110620_bb0120","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.ijbiomac.2017.11.031","article-title":"Glycol chitosan functionalized asenapine nanostructured lipid carriers for targeted brain delivery: pharmacokinetic and teratogenic assessment","volume":"108","author":"Singh","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.msec.2019.110620_bb0125","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/08982104.2015.1098659","article-title":"Nano-transfersomal formulations for transdermal delivery of asenapine maleate: in vitro and in vivo performance evaluations","volume":"26","author":"Shreya","year":"2016","journal-title":"J Liposome Res"},{"issue":"44","key":"10.1016\/j.msec.2019.110620_bb0130","first-page":"1","article-title":"Novel drug delivery approach via self-microemulsifying drug delivery system for enhancing oral bioavailability of asenapine maleate: optimization, characterization, cell uptake, and in vivo pharmacokinetic studies","volume":"20","author":"Patel","year":"2019","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.msec.2019.110620_bb0135","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/21691401.2018.1546186","article-title":"Enhanced intestinal absorption of asenapine maleate by fabricating solid lipid nanoparticles using TPGS: elucidation of transport mechanism, permeability across Caco-2 cell line and in vivo pharmacokinetic studies","volume":"47","author":"Patel","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1016\/j.msec.2019.110620_bb0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"Simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharma."},{"key":"10.1016\/j.msec.2019.110620_bb0145","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1517\/17425255.2014.908185","article-title":"Asenapine review, part I: chemistry, receptor affinity profile, pharmacokinetics and metabolism","volume":"10","author":"Citrome","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.msec.2019.110620_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2014.00138","article-title":"Orally administered liposomal formulations for colon targeted drug delivery","volume":"5","author":"Hua","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.msec.2019.110620_bb0155","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jconrel.2007.04.021","article-title":"PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination","volume":"120","author":"Garinot","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2019.110620_bb0160","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.addr.2013.01.003","article-title":"In vitro and in vivo models for the study of oral delivery of nanoparticles","volume":"65","author":"Gamboa","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.msec.2019.110620_bb0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1208\/s12249-018-1262-2","article-title":"Active targeting of drugs and bioactive molecules via oral administration by ligand-conjugated lipidic nanocarriers: recent advances","volume":"20","author":"Shreya","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.msec.2019.110620_bb0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0003-2697(80)90269-9","article-title":"Colorimetric determination of phospholipids with ammonium ferrothiocyanate","volume":"104","author":"Stewart","year":"1980","journal-title":"Anal. Biochem."}],"container-title":["Materials Science and Engineering: C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493119328346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493119328346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:58:25Z","timestamp":1760533105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928493119328346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":34,"alternative-id":["S0928493119328346"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2019.110620","relation":{},"ISSN":["0928-4931"],"issn-type":[{"value":"0928-4931","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surface engineered nanoliposomal platform for selective lymphatic uptake of asenapine maleate: In vitro and in vivo studies","name":"articletitle","label":"Article Title"},{"value":"Materials Science and Engineering: C","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2019.110620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110620"}}